Investigational Site Number: 403 — Palo Alto, California

Investigational Site Number: 403 is a clinical research site located in Palo Alto, California, United States 94304.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigational Site Number: 403 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Hormone-refractory Prostate Cancer.

Sponsors: Vir Biotechnology, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Palo Alto

Browse all research sites in California · View every site in Palo Alto

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number: 403?

Investigational Site Number: 403 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number: 403 conducted?

Investigational Site Number: 403 has 1 clinical trials on record, with 1 currently active. Their work covers Hormone-refractory Prostate Cancer.

Is Investigational Site Number: 403 accredited by Crixeo Clinical Trials?

Investigational Site Number: 403 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number: 403?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.